about
O-GlcNAcylation and Metabolic Reprograming in CancerTopoisomerase IIβ binding protein 1 c.*229C>T (rs115160714) gene polymorphism and endometrial cancer riskRate of positive urine culture and double-J catheters colonization on the basis of microorganism DNA analysis.Expression, localization, and phosphorylation of Akt1 in benign and malignant thyroid lesionsGene and protein expression of glucose transporter 1 and glucose transporter 3 in human laryngeal cancer-the relationship with regulatory hypoxia-inducible factor-1α expression, tumor invasiveness, and patient prognosis.Effect of metformin on apoptosis induction in ovarian cancer cells.Gene expression of O-GlcNAc cycling enzymes in human breast cancersExpression of GLUT1 and GLUT3 glucose transporters in endometrial and breast cancers.Expression of TopBP1 in hereditary breast cancerGene and protein expression of O-GlcNAc-cycling enzymes in human laryngeal cancer.Metallothionein 2A core promoter region genetic polymorphism and its impact on the risk, tumor behavior, and recurrences of sinonasal inverted papilloma (Schneiderian papilloma)Metallothionein 2A genetic polymorphisms and risk of ductal breast cancerThe potential role of O-GlcNAc modification in cancer epigenetics.Effect of Glucose on GLUT1-Dependent Intracellular Ascorbate Accumulation and Viability of Thyroid Cancer Cells.Down-regulation of β-N-acetyl-D-glucosaminidase increases Akt1 activity in thyroid anaplastic cancer cells.The effect of metallothionein 2A core promoter region single-nucleotide polymorphism on accumulation of toxic metals in sinonasal inverted papilloma tissues.The -5 A/G single-nucleotide polymorphism in the core promoter region of MT2A and its effect on allele-specific gene expression and Cd, Zn and Cu levels in laryngeal cancer.Metallothionein 2A genetic polymorphisms and risk of prostate cancer in a Polish population.Expression of hypoxia inducible factor 1α and 2α and its association with vitamin C level in thyroid lesions.Effect of metallothionein 2A gene polymorphism on allele-specific gene expression and metal content in prostate cancer.Gene/protein expression of CAPN1/2-CAST system members is associated with ERK1/2 kinases activity as well as progression and clinical outcome in human laryngeal cancer.Urinary thiosulfate as failed prostate cancer biomarker - an exemplary multicenter re-evaluation study.Genetic polymorphism of metallothionein 2A and risk of laryngeal cancer in a Polish population.Impact of OGT deregulation on EZH2 target genes FOXA1 and FOXC1 expression in breast cancer cells.Expression of hypoxia-related glucose transporters GLUT1 and GLUT3 in benign, malignant and non-neoplastic thyroid lesionsDifferences in glycosylation of intracellular proteins between benign and malignant thyroid neoplasmsAge-related patterns of lectin-binding nuclear glycoproteins of hamster liverRelationship between polycomb-group protein BMI-1 and phosphatases regulating AKT phosphorylation level in endometrial cancer
P50
Q27027028-952943B2-D1EA-4312-8F6D-9C18BF2ADBC4Q33775038-84BEAC73-B0ED-4437-ABD5-A45B94ECE5CDQ33819959-B959FB56-5E2F-489F-8613-C6BD32D96A10Q35589717-C4A2BB34-666B-44FA-AC1B-B02C59F631E6Q35596889-D1C34F34-99D6-4550-A2BA-3BD9DA907455Q35761271-38F1D651-1E44-42C0-BB2E-4B2467C9E6A3Q35809895-106437CE-0E23-4CB0-8813-A174C7F7CE66Q35928789-A246F672-ED78-4127-BE4F-05CED342A321Q35981641-6FA2DDB2-19A6-45E9-8B98-2312FEA10C12Q36214824-15A1AC27-8FDF-4272-908D-829D8F5134F3Q36352771-F534093A-A9CB-4367-B7CF-7626D8D4508EQ37535008-7C543226-ADBA-4E36-9D2E-66687C277D12Q38241688-B6209EBC-1997-4F8C-8232-970FEB981EA8Q38834684-C2AF9843-BD74-4EE4-9848-46B6462FF9E4Q39531239-28A52259-8031-4FDE-93BD-61E2C256AF00Q42701960-B5121B2A-1B03-4521-A9BB-4E8B18E9B881Q42704371-B3DC7E22-E844-4BDA-B3FF-F8D82AF192CBQ44686582-FF88A6C3-2873-4E4F-84AE-E06F91C7BE99Q46702112-BB5BF8B9-3D96-479C-AB84-AEA9121EECD6Q46864234-46AD3042-FAFC-422B-B20F-E85375B0BE68Q51617592-2845377D-F39B-4FD2-B017-8C59E7AD05BEQ53155529-73173AE1-3761-4415-A83D-2EF634F4A108Q54201489-34C0BBFD-3DF7-4C99-809F-FE580C01C7F6Q55131833-6D05FF29-227A-44D7-921C-297DD6DA7C07Q62691948-0AA434B2-BE90-4A48-9BBE-F8FD82B7B7D2Q62692049-99177448-E83A-41BC-A2BA-158108C5464AQ62692076-71EC3556-4173-498A-9FF1-03D0C58DC004Q92167697-807B88DA-E4F5-4ECA-B12B-D5991E4A5A05
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Anna Krześlak
@ast
Anna Krześlak
@en
Anna Krześlak
@es
Anna Krześlak
@nl
type
label
Anna Krześlak
@ast
Anna Krześlak
@en
Anna Krześlak
@es
Anna Krześlak
@nl
altLabel
56454374600
@en
prefLabel
Anna Krześlak
@ast
Anna Krześlak
@en
Anna Krześlak
@es
Anna Krześlak
@nl
P106
P1153
6602595673
P21
P31
P496
0000-0002-4982-7901